Keyphrases
Risk Level
100%
Reduction Strategies
100%
Breast Cancer Risk Reduction
100%
Personal Risk
100%
High Risk
66%
Breast Cancer
66%
Mastectomy
66%
Exemestane
66%
Discrete-time
33%
Risk Change
33%
Quality-adjusted Life Years
33%
Therapeutic Approaches
33%
Markov Decision Model
33%
Preventive Treatment
33%
Personal Factors
33%
National Comprehensive Cancer Network
33%
Risk-return Trade-off
33%
Postmenopausal Women
33%
High-risk Women
33%
Hormonal Therapy
33%
Hereditary Factors
33%
Raloxifene
33%
Risk Reduction Surgery
33%
Risk Reduction Strategies
33%
Leading Causes of Death
33%
National Clinical Guidelines
33%
Breast Cancer Risk
33%
Expected Quality
33%
Intervention Policies
33%
Medicine and Dentistry
Breast Cancer
100%
Cancer Risk Reduction
100%
Mastectomy
40%
Exemestane
40%
Decision Making
20%
Hormone Therapy
20%
Risk Reduction Surgery
20%
Risk Reduction
20%
Postmenopause
20%
Prophylaxis
20%
Clinical Guideline
20%
Quality Adjusted Life Year
20%
Malignant Neoplasm
20%
Raloxifene
20%
Tamoxifen
20%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Exemestane
40%
Malignant Neoplasm
20%
Hormone Cancer Therapy
20%
Tamoxifen
20%
Raloxifene
20%